JFG
WVE icon

Jefferies Financial Group’s Wave Life Sciences WVE Stock Holding History

Jefferies Financial Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-11,801
Closed -$51.1K – 2049
2023
Q1 		$51.1K Buy
+11,801
New +$54.1K ﹤0.01% 1487

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Jefferies Financial Group's WVE Position: Q2 2023 in Review

Jefferies Financial Group sold out of Wave Life Sciences (WVE) in Q2 2023, closing a stake of 11,801 shares — an estimated $51.1K sold.

Jefferies Financial Group first reported a position in WVE in Q1 2023 and held it in 1 quarter. The position peaked at $51.1K in Q1 2023. 81 funds tracked by Wall St. Rank hold WVE as of Q2 2023.

  • Jefferies Financial Group reported no remaining Wave Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Jefferies Financial Group sold 11,801 Wave Life Sciences shares in Q2 2023, an estimated $51.1K.
  • Jefferies Financial Group first reported a position in Wave Life Sciences in Q1 2023 and held it in 1 quarter.
  • Jefferies Financial Group's Wave Life Sciences position peaked at $51.1K in Q1 2023.
  • 81 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2023.

Based on Jefferies Financial Group's 13F filing for Q2 2023, filed 14 Aug 2023.